| Larsen Holyoak, ATC | |
|
98 N 1100 E Ste 402, American Fork, UT 84003-2951 | |
| (801) 492-2405 | |
| Not Available |
| Full Name | Larsen Holyoak |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 98 N 1100 E Ste 402, American Fork, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245750991 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 10408495-2401 (Utah) | Primary |
| 2255A2300X | Specialist/technologist - Athletic Trainer | 10408495-4810 (Utah) | Secondary |
| Provider Name | Ihc Health Services Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1033822085 PECOS PAC ID: 1850209420 Enrollment ID: O20230627000064 |
News Archive
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF's TVT Connect meeting (June 18-28, 2020).
Biocept, Inc., a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection, monitoring and treatment of cancer, announces a $15 million common stock purchase agreement with Aspire Capital Fund, LLC, a Chicago-based institutional investor.
Sen. John Kerry (D-Mass.) visited Pakistan on Thursday "to assess the damage and relief efforts" as flooding continues and millions remain in need of humanitarian aid, the New York Times reports. According to the newspaper, Kerry "said the United States would increase its flood aid to $150 million" (Masood/Gall, 8/19).
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larsen Holyoak, ATC 98 N 1100 E Ste 402, American Fork, UT 84003-2951 Ph: () - | Larsen Holyoak, ATC 98 N 1100 E Ste 402, American Fork, UT 84003-2951 Ph: (801) 492-2405 |
News Archive
Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.
PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF's TVT Connect meeting (June 18-28, 2020).
Biocept, Inc., a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection, monitoring and treatment of cancer, announces a $15 million common stock purchase agreement with Aspire Capital Fund, LLC, a Chicago-based institutional investor.
Sen. John Kerry (D-Mass.) visited Pakistan on Thursday "to assess the damage and relief efforts" as flooding continues and millions remain in need of humanitarian aid, the New York Times reports. According to the newspaper, Kerry "said the United States would increase its flood aid to $150 million" (Masood/Gall, 8/19).
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 9 days ago
Nickolas Arbon, Physical Therapist Medicare: Medicare Enrolled Practice Location: 358 N 1100 E # 4, American Fork, UT 84003 Phone: 385-304-4446 | |
Quintin D Warnick, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-763-3520 | |
Russell Jack Gatenby, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1184 E 80 N, American Fork, UT 84003 Phone: 801-756-7777 | |
Barbara B Moe, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 169 N 1100 E, American Fork, UT 84003 Phone: 801-472-2622 | |
Dr. Peter Franklin Fitts, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-855-3300 | |
Mr. Jesse Adam Craig, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-855-3437 | |
Mr. Derick J Woolf, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-763-3520 |